Sunday, September 17
SESSION 1: TRANSLATING ALZHEIMER'S DISEASE RESEARCH TO CLINICAL PRACTICE: HOW DO WE BRIDGE THE GAP?
SYMPOSIUM IS ORGANISED AND SUPPORTED BY Lilly
Sunday, September 17, 13:00-14:30, Annex Hall 1
Introduction
Atsushi Iwata, Japan
Therapeutic Targets and Strategies in Alzheimer's Disease Drug Development
Michael Irizarry, US
Clinical Implications of PET Neuroimaging Research in Alzheimer's Disease
Danna Jennings, US
Bridging the Gap Between Research and Clinical Practice in Alzheimer's Disease
Atsushi Iwata, Japan
Panel Discussion and Questions & Answers
All
Closing Remarks
Atsushi Iwata, Japan
***********
SESSION 2: THE BURDEN OF STROKE AND COGNITIVE IMPAIRMENT: CURRENT CHALLENGES & FUTURE PERSPECTIVES
SYMPOSIUM IS ORGANISED AND SUPPORTED BY Takeda
Sunday, September 17, 13:00-14:30, Room C-1
Chair: Alla Guekht, Russia
Stroke and Dementia: The Global Burden and Risk Factors
Valery Feigin, New Zealand
Key Challenges in Stroke Treatment and Prevention
Martin Köhrmann, Germany
Post-stroke Cognitive Impairment: Treatment Strategies
Alla Guekht, Russia
Q & A and Close
Alla Guekht, Russia
Monday, September 18
SESSION 3: DECISIONS THAT MATTER IN THE TREATMENT OF PEOPLE WITH MS
SYMPOSIUM IS ORGANISED AND SUPPORTED BY Biogen
Monday, September 18, 13:00-14:30, Room A
CO-CHAIRS' INTRODUCTION:
Building A Transformative Age in Neurology
Jun-ichi Kira, Japan
Living with MS, a Lifelong Disease with Individual Patient Needs
Hans-Peter Hartung, Germany
MS IN-DEPTH LECTURES:
Anticipating Patients' Needs Through Prognosis
Jin Nakahara, Japan
Optimizing Management of MS in an Age of Increasing Choice
Helmut Butzkueven, Australia
The Importance of Forward Planning in Treatment Sequencing
Timothy West, US
INTERACTIVE SESSION:
Audience Questions and Answers
All faculty
Conclusions and Final Remarks
Hans-Peter Hartung (Germany) and Jun-ichi Kira (Japan)
Tuesday, September 19
TAFAMIDIS TREATMENT FOR TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP): MANAGEMENT OF A RARE AND FATAL POLYNEUROPATHY
SYMPOSIUM IS ORGANISED AND SUPPORTED BY Pfizer
Tuesday, September 19, 13:00-14:30, Annex Hall 1
Co-Chair: Yukio Ando, Japan
Co-Chair: Márcia Waddington-Cruz, Brazil
Welcome
Co-Chairs
Identification and Recognition of TTR-FAP, A Rare and Fatal Disease
Yukio Ando, Japan
TTR-FAP – Guidelines for Patient Management
Laura Obici, Italy
The Efficacy and Safety of Tafamidis: The Most Studied Medicine for TTR-FAP
Fabio Barroso, Argentina
The Benefits of Early Intervention with Tafamidis
Márcia Waddington-Cruz, Brazil
Q&A Session
Moderated by Co-Chairs
***********
SESSION 5:
ONGOING EVOLUTION OF STANDARD OF CARE IN SPINAL MUSCULAR ATROPHY
SYMPOSIUM IS ORGANISED AND SUPPORTED BY Biogen
Tuesday, September 19, 13:00-14:30, Room A
Welcome and Introduction
Kayoko Saito, Japan
From Genetic Mutation to Motor Neuron Degeneration
Chien-Ping Ko, US
From Clinical Aspect, to Challenge, to Unmet Need in SMA: Why Early and Effective Intervention Matters?
Kayoko Saito, Japan
Innovations in SMA Management and Patient Care: Where are we going?
Kathryn J. Swoboda, USA
Conclusions and Closing Remarks
Kayoko Saito, Japan
